tr?id=&ev=PageView&noscript=
 DOA

DOA Antibodies & Antigens

Drug abuse testing traditionally refers to the practice of testing for drugs including depressants, hallucinogens, CNS stimulants, opiates, cannabinoids, and phencyclidine (PCP). Immunoassays for drug-testing are generally divided into forensic (DOA assays) and clinical products (TDM serum assays). Due to the differences in applications, there are distinct design, technical capabilities, and regulatory approval processes for each type. Meridian offers a range of drug testing reagents designed to produce accurate and precise results for both qualitative and quantitative assays.

Reagents for Assay Development in Drugs of Abuse (DOA)

Reagents for assay development in Drugs of Abuse (DOA) testing are critical for creating reliable diagnostic solutions. These specialized antibodies and antigens enable the detection of various substances, ensuring accurate and sensitive results in forensic and clinical settings. Designed for precision, these reagents support the development of advanced immunoassays, aiding in substance abuse monitoring and treatment strategies. Their use contributes significantly to public health and safety efforts worldwide.

Not seeing what you’re looking for? Inquire about a new product

Get In Touch With A Specialist

Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!


By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
Learn More About Us
Learn More
Welcome to
logo blue

Please select your country to continue

Continue
CN